Platelet News and Research

RSS

Patient-specific dosimetry can improve treatment for neuroendocrine tumors

In neuroendocrine tumor treatment, different methods of predicting patient response may be required for different patients, according to new research published in the October issue of The Journal of Nuclear Medicine. By tailoring the method to the specific patient, physicians may better predict the effectiveness of treatment.

30 Oct 2019

Kazan University researchers study the genetics of nephropathia epidemica

This particular inquiry pertains to CCR5 - a gene which has lately been on the focuses of research worldwide. In particular, CCR5 deletion was used in China to perform the first ever genetic editing on human embryos. It's also known that a CCR5-Δ32 mutation can make people immune to HIV.

10 Oct 2019

Exercise can help protect cancer patients' heart from negative effects of therapies

Patients with cancer should receive a tailored exercise prescription to protect their heart, reports a paper published today in the European Journal of Preventive Cardiology, a journal of the European Society of Cardiology.

7 Oct 2019

Exercise may help reduce heart damage caused by chemotherapy

Cancer treatments can take a toll on the heart. The agents used to curb cancer cells can damage the heart or peripheral blood vessels. In some cases, they cause problems with clotting or blood lipids.

7 Oct 2019

Review examines the role of biologic agents in management of shoulder and elbow problems

The utilization of stem cell therapies for augmentation of tissue healing has far outpaced the supporting scientific and clinical data, largely due to aggressive marketing that has led to widespread and often inappropriate use of cell therapy approaches in the United States.

1 Oct 2019

New $1.5 million grant could help develop innovative methods to halt spread of cancer

One of the most devastating pieces of news a cancer patient can receive is that their cancer has spread to other parts of the body.

1 Oct 2019

Combination therapy may offer new therapeutic avenue for previously-treated NSCLC and kidney cancer patients

Pegilodecakin, a first-in-class drug currently in clinical trials, has shown positive safety results and may offer a potential new treatment avenue for patients with non-small cell lung cancer and kidney cancer.

26 Sep 2019

Investigational drug may offer new treatment option for patients with lung and kidney cancer

26 Sep 2019

Study highlights need to educate women and medical community about risk factors of preeclampsia

Despite its crowded healthcare market and strong efforts to make healthcare more accessible to patients, New Jersey has one of the highest maternal mortality rates in the nation - an issue so pertinent that First Lady Tammy Murphy created the Nurture NJ initiative to help reduce infant and maternal mortality.

20 Sep 2019

Low-dose aspirin may improve survival in patients with head and neck, lung cancers

What if a drug that sits in nearly everyone's medicine cabinet could help extend the lives of some cancer patients? In companion presentations at the American Society for Therapeutic Radiation Oncology Annual Meeting in Chicago, doctors from Roswell Park Comprehensive Cancer Center report new evidence that low-dose aspirin and other anti-inflammatories may improve survival in patients undergoing treatment for some head/neck and lung cancers.

19 Sep 2019

5 million gift will help create Edward P. Evans Center for MDS at Dana-Farber

A $5 million gift from the Edward P. Evans Foundation will create the Edward P. Evans Center for Myelodysplastic Syndromes at Dana-Farber Cancer Institute.

17 Sep 2019

Mutant live attenuated Ebola virus elicits protective immunity in monkeys

Inoculation with an Ebola virus that has mutations in a protein called VP35 does not cause disease and elicits protection in monkeys, researchers show September 17 in the journal Cell Reports.

17 Sep 2019

New biomarkers help predict response to treatment in common brain tumor

Many scientists have noted that there is a link between inflammation or the immune response, and patient survival. One such possible relationship is the association of blood markers and the prognosis in the brain tumor called medulloblastoma.

16 Sep 2019

NYU Langone performs first-ever foot and ankle arthroscopic procedure with new camera system

NYU Langone Health recently became the first ever health system to perform a foot and ankle arthroscopic procedure with a new camera system for minimally invasive surgery that requires only local anesthesia.

16 Sep 2019

Researchers find synergistic connection between two deadly blood-clotting diseases

Two rare but potentially deadly blood-clotting diseases, namely thrombotic thrombocytopenic purpura, or TTP, and hemolytic uremic syndrome, or HUS, show similar pathologies -- a multitude of painful blockages in small blood vessels that cause varying degrees of organ injury throughout the body. However, the two disorders have distinct biological mechanisms.

8 Sep 2019

UTEP School of Pharmacy receives $1.8 million NIH grant to study the effects of thirdhand smoke

Researchers at The University of Texas at El Paso's School of Pharmacy have been awarded $1.8 million from the National Heart, Lung and Blood Institute of the National Institutes of Health to study the effects of thirdhand smoke on platelet function and cardiovascular disease such as heart attack and stroke.

4 Sep 2019

Ticagrelor reduces heart attacks and strokes for patients with diabetes

In late-breaking clinical trial results presented in a Hot Line Session today at the European Society of Cardiology Congress 2019, investigators from Brigham and Women's Hospital and Greater Paris University Hospitals - AP-HP/Université de Paris presented the results from The Effect of Ticagrelor on Health Outcomes in Diabetes Mellitus Patients Intervention Study, a clinical trial sponsored by AstraZeneca that evaluated whether adding ticagrelor to aspirin improves outcomes for patients with stable coronary artery disease and diabetes mellitus but without a history of heart attack or stroke.

3 Sep 2019